We demonstrated that both major genetic AMD risk factors, the CFH H402 variant and a 10q26 haplotype, inhibit TSP1-mediated CD47 activation and MP elimination, promoting pathogenic inflammation [17, 18]. This evidence concerns the gene CD47 and age-related macular degeneration.